Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchIndependent Academic Research Groups
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

NYU Langone Health

United States
10 Trials

Home to the NYU Langone Center for Psychedelic Medicine, one of the world's leading academic institutions in psychedelic research. Has conducted landmark psilocybin trials for smoking cessation, alcohol use disorder, and depression in cancer patients, spearheaded by Dr. Michael Bogenschutz and colleagues.

Academic Research

0 papers

Published Papers

0

Trial Involvement

10

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
United States
Website
Visit

Sponsored Trials

9
Not yet recruitingII

Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter

Start Date
Compounds
Psilocybin, Placebo
RecruitingII

Psilocybin for Opioid Use Disorder (OUD)

Start Date
Compounds
Psilocybin
Not yet recruitingI

Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)

Start Date
Compounds
Psilocybin, Placebo
RecruitingII

Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD

Start Date
Compounds
Psilocybin, Placebo
RecruitingII, III

Psilocybin Therapy in Advanced Cancer

Start Date
Compounds
Psilocybin, Placebo
CompletedI

The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals

Start Date
Compounds
Psilocybin
CompletedII

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

Start Date
Compounds
Psilocybin, Placebo
CompletedII

Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients

Start Date
Compounds
Ketamine, Placebo
CompletedI

Psilocybin Cancer Anxiety Study

Start Date
Compounds
Psilocybin, Placebo

Collaborated Trials

1
RecruitingI

Safety and Tolerability Trial of Psilocybin in Healthy Older Adults

Start Date
Compounds
Psilocybin